Are These The Small-Cap Health Care Stocks To Buy Or Sell This Week?
Over the past decade, health care stocks have been one of the best performing sectors within the S&P 500. Even though we live in an era with impressive technologies, there are still diseases with ineffective treatments. Some diseases have no treatment at all. This is where up and coming health care stocks could make it big. The market potential is huge for these companies and it makes them the best health care stocks to buy right now.
It has become clearer that we will need far more investment and modernization in this space. The current pandemic has shaken the country. Politicians and industry leaders will be spending heavily to avoid similar outcomes from happening again in the future. But there are also other diseases that are equally threatening to the human population. That said, some investors are loading up the best health care stocks in the market. What’s interesting is that these stocks could include both big cap and small-cap stocks. Despite having more resources, there is no guarantee that large biotech companies will necessarily be the first to come up with successful products for Covid-19.
Of course, small-cap health care stocks can be knocked out of the market by the bigger players. Or, they could run out of cash and have to discontinue their operations altogether. All of this makes the small-cap health care stocks riskier to own in the first place. But hey, great risk comes great reward, right? And because of these higher risks, investors should do their research before investing. There are a few things to note when it comes to investing in health care stocks. For instance, investors might want to consider what’s in the pipeline, partnerships, and the financial state of the company. Now that there are two health care stocks making big moves recently, the question is, are these health care stocks on your watchlist?
Read More
- Are These Biotech Stocks Benefiting From The Resurgence Of Coronavirus Cases?
- Is Virgin Galactic The Best Aerospace Stock To Watch Right Now?
- Tesla Stock Surges Past $1,000; What’s Next?
Best Small Cap Health Care Stocks To Trade Now: T2 Biosystems Inc.
First, up the list, T2 Biosystems (TTOO Stock Report) has completed the validation of its T2SARS-CoV-2 Panel, its molecular test for Covid-19. Commercial launch is underway under emergency use authorization. The need for highly accurate testing is becoming increasingly prominent as more cases are detected globally, making it harder for us to beat the virus. The later we distribute fast and effective testing kits to every part of the world, the harder it is for us to eliminate the virus completely.
The T2SARS-CoV-2 Panel runs on the company’s T2Dx Instrument, an automated, random access system capable of performing seven tests simultaneously. The test, utilizing a nasopharyngeal swab sample, could obtain the results in less than two hours. This compares favourably to some other tests which take days. On top of that, the company also announced its interim Q2 earnings and estimated revenue in the range of $2.4-$2.6 million, compared to $1.8 million in the same period last year. Considering the need for more testing globally, will TTOO stock be in the position for a huge breakout this week?
[Read More] Are These 2 Top Tech Stocks A Buy In 2020?
Best Small Cap Health Care Stocks To Trade Now: OPKO Health Inc.
The shares of OPKO Health (OPK Stock Report) first gained investors’ attention in early March. That was when the company’s Bioreference Laboratories unit introduced a Covid-19 test. The company ramped up its Covid-19 efforts, launching drive-through testing in New York and then in New Jersey, as well as Detroit and Miami. As a result, investors in OPKO Health have been handsomely rewarded recently. The combination of strong price performance could suggest that OPK stock may be able to march higher after recent climbs.
But OPKO’s coronavirus effort isn’t just limited to testing. In June, the FDA gave a green light for the company to begin a phase 2 clinical trial evaluating its drug, Rayaldee as a treatment for patients with mild-to-moderate cases of Covid-19. Rayaldee, which is supposedly meant for treating thyroid-related problems, is suddenly a potential growth driver for the company’s business. All in all, the company’s new Covid-19 tests should be able to fuel growth in the foreseeable future. With both testing and potential treatment capabilities, is OPK stock one of the best health care stocks to buy in the market right now?
